PLoS ONE (Jan 2011)

Identification of methylated genes associated with aggressive clinicopathological features in mantle cell lymphoma.

  • Anna Enjuanes,
  • Verònica Fernàndez,
  • Luis Hernández,
  • Alba Navarro,
  • Sílvia Beà,
  • Magda Pinyol,
  • Armando López-Guillermo,
  • Andreas Rosenwald,
  • German Ott,
  • Elías Campo,
  • Pedro Jares

DOI
https://doi.org/10.1371/journal.pone.0019736
Journal volume & issue
Vol. 6, no. 5
p. e19736

Abstract

Read online

BackgroundMantle cell lymphoma (MCL) is genetically characterized by the t(11;14)(q13;q32) translocation and a high number of secondary chromosomal alterations. The contribution of DNA methylation to MCL lymphomagenesis is not well known. We sought to identify epigenetically silenced genes in these tumours that might have clinical relevance.Methodology/principal findingsTo identify potential methylated genes in MCL we initially investigated seven MCL cell lines treated with epigenetic drugs and gene expression microarray profiling. The methylation status of selected candidate genes was validated by a quantitative assay and subsequently analyzed in a series of primary MCL (n = 38). After pharmacological reversion we identified 252 potentially methylated genes. The methylation analysis of a subset of these genes (n = 25) in the MCL cell lines and normal B lymphocytes confirmed that 80% of them were methylated in the cell lines but not in normal lymphocytes. The subsequent analysis in primary MCL identified five genes (SOX9, HOXA9, AHR, NR2F2, and ROBO1) frequently methylated in these tumours. The gene methylation events tended to occur in the same primary neoplasms and correlated with higher proliferation, increased number of chromosomal abnormalities, and shorter survival of the patients.ConclusionsWe have identified a set of genes whose methylation degree and gene expression levels correlate with aggressive clinicopathological features of MCL. Our findings also suggest that a subset of MCL might show a CpG island methylator phenotype (CIMP) that may influence the behaviour of the tumours.